Pathogenicity |
In-laboratory quality control of nutrients for automatic bacteriology analyzer YUNON(R)Labstar 50. |
Boronina LG, Samatova EV, Kukushkina MP, Panova SA, Ustyugova SS |
Klin Lab Diagn |
10.51620/0869-2084-2021-66-2-110-114 |
2021 |
* |
Phylogeny |
Dual Inhibition of Salmonella enterica and Clostridium perfringens by New Probiotic Candidates Isolated from Chicken Intestinal Mucosa. |
Lone A, Mottawea W, Ait Chait Y, Hammami R |
Microorganisms |
10.3390/microorganisms9010166 |
2021 |
* |
Phylogeny |
Biodiversity and Phylogenetic Relationships of Novel Bacteriocinogenic Strains Isolated from Animal's Droppings at the Zoological Garden of Lille, France. |
Eveno M, Salouhi A, Belguesmia Y, Bazinet L, Gancel F, Fliss I, Drider D |
Probiotics Antimicrob Proteins |
10.1007/s12602-020-09657-4 |
2021 |
* |
Phylogeny |
Antibiotic resistance, genome analysis and further safe traits of Clostridium perfringens ICVB082; a strain capable of producing an inhibitory compound directed only against a closely related pathogenic strain. |
Vieco-Saiz N, Belguesmia Y, Vachee A, Le Marechal C, Salvat G, Drider D |
Anaerobe |
10.1016/j.anaerobe.2020.102177 |
2020 |
* |
Pathogenicity |
beta-Lactam resistance development affects binding of penicillin-binding proteins (PBPs) of Clostridium perfringens to the fluorescent penicillin, BOCILLIN FL. |
Park M, Sutherland JB, Rafii F |
Anaerobe |
10.1016/j.anaerobe.2020.102179 |
2020 |
* |
Phylogeny |
Capsular Polysaccharide Is a Receptor of a Clostridium perfringens Bacteriophage CPS1. |
Ha E, Chun J, Kim M, Ryu S |
Viruses |
10.3390/v11111002 |
2019 |
* |
Pathogenicity |
[A study on clinical application of a novel reagent detecting toxigenic strains of Clostridium difficile]. |
Wang SM, Wang ZY |
Zhonghua Yi Xue Za Zhi |
10.3760/cma.j.issn.0376-2491.2018.48.013 |
2018 |
* |
Biotechnology |
Evaluation of Lactobacillus plantarum encapsulated with Eleutherine americana oligosaccharide extract as food additive in yoghurt. |
Phoem AN, Mayiding A, Saedeh F, Permpoonpattana P |
Braz J Microbiol |
10.1007/s42770-018-0017-2 |
2018 |
* |
Enzymology |
Enzymatic Synthesis of 6'-Sialyllactose, a Dominant Sialylated Human Milk Oligosaccharide, by a Novel exo-alpha-Sialidase from Bacteroides fragilis NCTC9343. |
Guo L, Chen X, Xu L, Xiao M, Lu L |
Appl Environ Microbiol |
10.1128/AEM.00071-18 |
2018 |
* |
Metabolism |
Structural characterization of wall and lipidated polysaccharides from Clostridium perfringens ATCC 13124. |
Vinogradov E, Aubry A, Logan SM |
Carbohydr Res |
10.1016/j.carres.2017.06.003 |
2017 |
* |
Pathogenicity |
Effect of continuous sub-culturing on infectivity of Clostridium perfringens ATCC13124 in mouse gas gangrene model. |
Kumar RB, Alam SI |
Folia Microbiol (Praha) |
10.1007/s12223-017-0503-1 |
2017 |
* |
Enzymology |
Exposure to beta-lactams results in the alteration of penicillin-binding proteins in Clostridium perfringens. |
Park M, Rafii F |
Anaerobe |
10.1016/j.anaerobe.2017.02.004 |
2017 |
* |
Stress |
Effect of Trehalose and Trehalose Transport on the Tolerance of Clostridium perfringens to Environmental Stress in a Wild Type Strain and Its Fluoroquinolone-Resistant Mutant. |
Park M, Mitchell WJ, Rafii F |
Int J Microbiol |
10.1155/2016/4829716 |
2016 |
* |
Enzymology |
Efficient and Regioselective Synthesis of beta-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating beta-N-Acetylhexosaminidase from Bifidobacterium bifidum. |
Chen X, Xu L, Jin L, Sun B, Gu G, Lu L, Xiao M |
Appl Environ Microbiol |
10.1128/AEM.01325-16 |
2016 |
* |
Metabolism |
Putative function of hypothetical proteins expressed by Clostridium perfringens type A strains and their protective efficacy in mouse model. |
Alam SI, Dwivedi P |
Infect Genet Evol |
10.1016/j.meegid.2016.06.040 |
2016 |
* |
Pathogenicity |
Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits. |
Zhou YF, Yu Y, Sun J, Tao MT, Zhou WJ, Li X, Liao XP, Liu YH |
Anaerobe |
10.1016/j.anaerobe.2016.04.005 |
2016 |
* |
Metabolism |
The Details of Glycolipid Glycan Hydrolysis by the Structural Analysis of a Family 123 Glycoside Hydrolase from Clostridium perfringens. |
Noach I, Pluvinage B, Laurie C, Abe KT, Alteen MG, Vocadlo DJ, Boraston AB |
J Mol Biol |
10.1016/j.jmb.2016.03.020 |
2016 |
* |
Enzymology |
Cloning, characterization, and production of three alpha-L-fucosidases from Clostridium perfringens ATCC 13124. |
Fan S, Zhang H, Chen X, Lu L, Xu L, Xiao M |
J Basic Microbiol |
10.1002/jobm.201500582 |
2015 |
* |
Genetics |
Identification of a Bacteria-Specific Binding Protein from the Sequenced Bacterial Genome. |
Kong M, Ryu S |
J Microbiol Biotechnol |
10.4014/jmb.1510.10056 |
2016 |
* |
Biotechnology |
Changes in microbial community during biohydrogen production using gamma irradiated sludge as inoculum. |
Yin Y, Wang J |
Bioresour Technol |
10.1016/j.biortech.2015.10.027 |
2015 |
* |
Enzymology |
Comparative analysis of extractable proteins from Clostridium perfringens type A and type C strains showing varying degree of virulence. |
Dwivedi P, Alam SI, Kumar O, Kumar RB |
Anaerobe |
10.1016/j.anaerobe.2015.07.006 |
2015 |
* |
Pathogenicity |
Inhibition of Clostridium perfringens growth by potassium lactate during an extended cooling of cooked uncured ground turkey breasts. |
Kennedy KM, Milkowski AL, Glass KA |
J Food Prot |
10.4315/0362-028X.JFP-13-106 |
2013 |
* |
Pathogenicity |
Growth-Inhibiting and morphostructural effects of constituents identified in Asarum heterotropoides root on human intestinal bacteria. |
Perumalsamy H, Jung MY, Hong SM, Ahn YJ |
BMC Complement Altern Med |
10.1186/1472-6882-13-245 |
2013 |
* |
Pathogenicity |
Effect of fluoroquinolone resistance selection on the fitness of three strains of Clostridium perfringens. |
Park M, Sutherland JB, Kim JN, Rafii F |
Microb Drug Resist |
10.1089/mdr.2013.0056 |
2013 |
* |
Pathogenicity |
A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens. |
Nagahama M, Oda M, Kobayashi K, Ochi S, Takagishi T, Shibutani M, Sakurai J |
Microbiol Immunol |
10.1111/1348-0421.12036 |
2013 |
* |
Pathogenicity |
Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens. |
Park S, Park M, Rafii F |
BMC Microbiol |
10.1186/1471-2180-13-50 |
2013 |
* |
Metabolism |
Structural analysis of CPF_2247, a novel alpha-amylase from Clostridium perfringens. |
Ficko-Blean E, Stuart CP, Boraston AB |
Proteins |
10.1002/prot.23116 |
2011 |
* |
Enzymology |
Lytic enzyme discovery through multigenomic sequence analysis in Clostridium perfringens. |
Schmitz JE, Ossiprandi MC, Rumah KR, Fischetti VA |
Appl Microbiol Biotechnol |
10.1007/s00253-010-2982-8 |
2010 |
* |
Pathogenicity |
Comparison of a nontoxic variant of Clostridium perfringens alpha-toxin with the toxic wild-type strain. |
Vachieri SG, Clark GC, Alape-Giron A, Flores-Diaz M, Justin N, Naylor CE, Titball RW, Basak AK |
Acta Crystallogr D Biol Crystallogr |
10.1107/S090744491003369X |
2010 |
* |
Enzymology |
Comparative proteomic analysis of extracellular proteins of Clostridium perfringens type A and type C strains. |
Sengupta N, Alam SI, Kumar B, Kumar RB, Gautam V, Kumar S, Singh L |
Infect Immun |
10.1128/IAI.00374-10 |
2010 |
* |
Pathogenicity |
Virulence for chickens of Clostridium perfringens isolated from poultry and other sources. |
Cooper KK, Theoret JR, Stewart BA, Trinh HT, Glock RD, Songer JG |
Anaerobe |
10.1016/j.anaerobe.2010.02.006 |
2010 |
* |
Metabolism |
Differential proteomic analysis of Clostridium perfringens ATCC13124; identification of dominant, surface and structure associated proteins. |
Alam SI, Bansod S, Kumar RB, Sengupta N, Singh L |
BMC Microbiol |
10.1186/1471-2180-9-162 |
2009 |
* |
Metabolism |
Characterization of two putative fibronectin-binding proteins of Clostridium perfringens. |
Katayama S, Nozu N, Okuda M, Hirota S, Yamasaki T, Hitsumoto Y |
Anaerobe |
10.1016/j.anaerobe.2009.03.001 |
2009 |
* |
Proteome |
Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies. |
Alam SI, Bansod S, Singh L |
BMC Microbiol |
10.1186/1471-2180-8-194 |
2008 |
* |
Enzymology |
Identification of galacto-N-biose phosphorylase from Clostridium perfringens ATCC13124. |
Nakajima M, Nihira T, Nishimoto M, Kitaoka M |
Appl Microbiol Biotechnol |
10.1007/s00253-007-1319-8 |
2008 |
* |
Pathogenicity |
Carbon catabolite repression of type IV pilus-dependent gliding motility in the anaerobic pathogen Clostridium perfringens. |
Mendez M, Huang IH, Ohtani K, Grau R, Shimizu T, Sarker MR |
J Bacteriol |
10.1128/JB.01407-07 |
2007 |
* |
Metabolism |
Detection of fibronectin-binding proteins in Clostridium perfringens. |
Katayama S, Nozu N, Yokoyama M, Hitsumoto Y |
Acta Med Okayama |
10.18926/AMO/30720 |
2006 |
* |
Genetics |
Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. |
Myers GS, Rasko DA, Cheung JK, Ravel J, Seshadri R, DeBoy RT, Ren Q, Varga J, Awad MM, Brinkac LM, Daugherty SC, Haft DH, Dodson RJ, Madupu R, Nelson WC, Rosovitz MJ, Sullivan SA, Khouri H, Dimitrov GI, Watkins KL, Mulligan S, Benton J, Radune D, Fisher DJ, Atkins HS, Hiscox T, Jost BH, Billington SJ, Songer JG, McClane BA, Titball RW, Rood JI, Melville SB, Paulsen IT |
Genome Res |
10.1101/gr.5238106 |
2006 |
* |
Enzymology |
Cloning, recombinant production, crystallization and preliminary X-ray diffraction studies of a family 84 glycoside hydrolase from Clostridium perfringens. |
Ficko-Blean E, Boraston AB |
Acta Crystallogr Sect F Struct Biol Cryst Commun |
10.1107/S1744309105024012 |
2005 |
* |
Metabolism |
Inhibition of Clostridium perfringens by a novel strain of Bacillus subtilis isolated from the gastrointestinal tracts of healthy chickens. |
Teo AY, Tan HM |
Appl Environ Microbiol |
10.1128/AEM.71.8.4185-4190.2005 |
2005 |
* |
Cultivation |
Susceptibility of Clostridium perfringens to C-C fatty acids. |
Skrivanova E, Marounek M, Dlouha G, Kanka J |
Lett Appl Microbiol |
10.1111/j.1472-765X.2005.01709.x |
2005 |
* |
Pathogenicity |
Growth inhibition of intestinal bacteria and mutagenicity of 2-, 3-, 4-aminobiphenyls, benzidine, and biphenyl. |
Chung KT, Adris P |
Toxicol In Vitro |
10.1016/s0887-2333(02)00131-5 |
2003 |
* |
Pathogenicity |
Activity of endodontic antibacterial agents against selected anaerobic bacteria. |
Ferreira CM, da Silva Rosa OP, Torres SA, Ferreira FB, Bernardinelli N |
Braz Dent J |
10.1590/s0103-64402002000200008 |
2002 |
* |
Pathogenicity |
In vitro effect of intracanal medicaments on strict anaerobes by means of the broth dilution method. |
Rosa OP, Torres SA, Ferreira CM, Ferreira FB |
Pesqui Odontol Bras |
10.1590/s1517-74912002000100006 |
2002 |
* |
Pathogenicity |
Bactericidal properties of the chloroform fraction from rhizomes of Aristolochia paucinervis Pomel. |
Gadhi CA, Hatier R, Mory F, Marchal L, Weber M, Benharref A, Jana M, Lozniewski A |
J Ethnopharmacol |
10.1016/s0378-8741(01)00185-4 |
2001 |
* |
Cultivation |
An effective lacticin biopreservative in fresh pork sausage. |
Scannell AG, Ross RP, Hill C, Arendt EK |
J Food Prot |
10.4315/0362-028x-63.3.370 |
2000 |
* |
Enzymology |
A Clostridium perfringens hem gene cluster contains a cysG(B) homologue that is involved in cobalamin biosynthesis. |
Koyama M, Katayama S, Kaji M, Taniguchi Y, Matsushita O, Minami J, Morita S, Okabe A |
Microbiol Immunol |
10.1111/j.1348-0421.1999.tb03355.x |
1999 |
* |
Phylogeny |
Crystallization and preliminary X-ray diffraction studies of alpha-toxin from two different strains (NCTC8237 and CER89L43) of Clostridium perfringens. |
Basak AK, Howells A, Eaton JT, Moss DS, Naylor CE, Miller J, Titball RW |
Acta Crystallogr D Biol Crystallogr |
10.1107/s0907444998005186 |
1998 |
* |
Phylogeny |
Evaluation of the synergistic haemolysis (CAMP-like) test in the identification of motile, mesophilic Aeromonas species. |
Gubash SM |
Zentralbl Bakteriol |
10.1016/s0934-8840(97)80073-4 |
1997 |
* |
Genetics |
Collagenase gene (colA) is located in the 3'-flanking region of the perfringolysin O (pfoA) locus in Clostridium perfringens. |
Ohtani K, Bando M, Swe T, Banu S, Oe M, Hayashi H, Shimizu T |
FEMS Microbiol Lett |
10.1111/j.1574-6968.1997.tb10186.x |
1997 |
* |
Phylogeny |
Improved isolation of Clostridium perfringens from foal faeces. |
Netherwood T, Chanter N, Mumford JA |
Res Vet Sci |
10.1016/s0034-5288(96)90090-9 |
1996 |
* |
Metabolism |
Characterization of a toxin-deficient Clostridium perfringens strain, KZ1340. |
Shimizu T, Ohtani K, Ba-Thein W, Inui S, Nakamura S, Hayashi H |
Microbiol Immunol |
10.1111/j.1348-0421.1996.tb03329.x |
1996 |
* |
Pathogenicity |
Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals. |
Ginter A, Williamson ED, Dessy F, Coppe P, Bullifent H, Howells A, Titball RW |
Microbiology (Reading) |
10.1099/13500872-142-1-191 |
1996 |
* |
Enzymology |
Diversity in the properties of two sialidase isoenzymes produced by Clostridium perfringens spp. |
Roggentin P, Kleineidam RG, Schauer R |
Biol Chem Hoppe Seyler |
10.1515/bchm3.1995.376.9.569 |
1995 |
* |
Phylogeny |
Synthesis and evaluation of a non-radioactive gene probe for the detection of C.perfringens alpha toxin. |
Schlapp T, Blaha I, Bauerfeind R, Wieler LH, Schoepe H, Weiss R, Baljer G |
Mol Cell Probes |
10.1016/s0890-8508(95)80034-4 |
1995 |
* |
Metabolism |
Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis. |
Ninomiya M, Matsushita O, Minami J, Sakamoto H, Nakano M, Okabe A |
Infect Immun |
10.1128/iai.62.11.5032-5039.1994 |
1994 |
* |
Phylogeny |
16S ribosomal DNA sequences of anaerobic cocci and proposal of Ruminococcus hansenii comb. nov. and Ruminococcus productus comb. nov. |
Ezaki T, Li N, Hashimoto Y, Miura H, Yamamoto H |
Int J Syst Bacteriol |
10.1099/00207713-44-1-130 |
1994 |
* |
Genetics |
Comparison of the alpha-toxin genes of Clostridium perfringens type A and C strains: evidence for extragenic regulation of transcription. |
Katayama S, Matsushita O, Minami J, Mizobuchi S, Okabe A |
Infect Immun |
10.1128/iai.61.2.457-463.1993 |
1993 |
* |
Enzymology |
Collagenase of Clostridium perfringens type A: degradation of human complement component C1q. |
Wolf U, Bauer D, Traub WH |
Zentralbl Bakteriol |
10.1016/s0934-8840(11)80215-x |
1991 |
* |
Pathogenicity |
Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem. |
Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA |
J Clin Microbiol |
10.1128/jcm.28.12.2804-2805.1990 |
1990 |
* |
Pathogenicity |
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria. |
Zabransky RJ, Bobey DG, Barry AL, Allen SD, Fuchs PC, Gerlach EH, Thornsberry C, Sheikh W, Jones RN |
J Clin Microbiol |
10.1128/jcm.27.1.190-191.1989 |
1989 |
* |
Enzymology |
Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product. |
Tweten RK |
Infect Immun |
10.1128/iai.56.12.3228-3234.1988 |
1988 |
* |
Cultivation |
Growth curves of Clostridium perfringens in Schaedler and brain heart infusion broths. |
Traub WH, Spohr M, Bauer D |
Zentralbl Bakteriol Mikrobiol Hyg A |
10.1016/s0176-6724(87)80035-4 |
1987 |
* |
Cultivation |
Evaluation of some commercial media for the cultivation and enumeration of Clostridium perfringens from the chick intestine. |
Dafwang II, Ricke SC, Schaefer DM, Brotz PG, Sunde ML, Pringle DJ |
Poult Sci |
10.3382/ps.0660652 |
1987 |
* |
Pathogenicity |
Effect of antibiotics on toxin production and viability of Clostridium perfringens. |
Stevens DL, Maier KA, Mitten JE |
Antimicrob Agents Chemother |
10.1128/AAC.31.2.213 |
1987 |
* |
Enzymology |
Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase. |
Malouin F, Fijalkowski C, Lamothe F, Lacroix JM |
Antimicrob Agents Chemother |
10.1128/AAC.30.5.749 |
1986 |
* |
Pathogenicity |
Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques. |
Sutter VL, Emmerman J, Randall E, Zabransky RJ, Birk RJ |
Antimicrob Agents Chemother |
10.1128/AAC.27.3.424 |
1985 |
* |
Pathogenicity |
Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum. |
Mangels JI, Lindberg LH |
J Clin Microbiol |
10.1128/jcm.21.2.269-272.1985 |
1985 |
* |
Pathogenicity |
Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms. |
Zabransky RJ, Randall E, Sutter VL, Birk RJ, Westenfelder G, Emmerman J, Ghoneim AT |
J Clin Microbiol |
10.1128/jcm.17.4.711-714.1983 |
1983 |
* |
Cultivation |
Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. |
Sutter VL, Barry AL, Wilkins TD, Zabransky RJ |
Antimicrob Agents Chemother |
10.1128/AAC.16.4.495 |
1979 |
* |
Pathogenicity |
Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. |
Mollby R, Holme T, Nord CE, Smyth CJ, Wadstrom T |
J Gen Microbiol |
10.1099/00221287-96-1-137 |
1976 |
* |
|
Galleria mellonella Infection Model Identifies Both High and Low Lethality of Clostridium perfringens Toxigenic Strains and Their Response to Antimicrobials. |
Kay S, Edwards J, Brown J, Dixon R |
Front Microbiol |
10.3389/fmicb.2019.01281 |
2019 |
* |
|
Inhibition of Clostridium perfringens using Bacteriophages and Bacteriocin Producing Strains. |
Heo S, Kim MG, Kwon M, Lee HS, Kim GB |
Korean J Food Sci Anim Resour |
10.5851/kosfa.2018.38.1.88 |
2018 |
* |
|
Screening of Bacteriocin-producing Enterococcus faecalis Strains for Antagonistic Activities against Clostridium perfringens. |
Han SK, Shin MS, Park HE, Kim SY, Lee WK |
Korean J Food Sci Anim Resour |
10.5851/kosfa.2014.34.5.614 |
2014 |
* |
|
Use of gamma-irradiation to reduce Clostridium perfringens on ready-to-eat bovine tripe. |
Parry-Hanson A, Hall A, Minnaar A, Buys EM |
Meat Sci |
10.1016/j.meatsci.2007.06.010 |
2007 |
* |
|
Immunogenicity of a newly developed vaccine against Clostridium perfringens alpha-toxin in rabbits and cattle. |
Saadh MJ, Lafi FF, Dahadha AA, Albannan MS |
Vet World |
10.14202/vetworld.2022.1617-1623 |
2022 |
* |